HEADER MEMBRANE PROTEIN 26-APR-25 9R1H TITLE INWARD-OCCLUDED STRUCTURE OF HUMAN GLYCINE TRANSPORTER 2 BOUND TO TITLE 2 SUBSTRATE GLYCINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SODIUM- AND CHLORIDE-DEPENDENT GLYCINE TRANSPORTER 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GLYT-2,GLYT2,SOLUTE CARRIER FAMILY 6 MEMBER 5; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC6A5, GLYT2, NET1; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: EXPI293F KEYWDS TRANSPORT PROTEIN, SLC6A5, NEUROTRANSMITTER/SODIUM SYMPORTER, SODIUM- KEYWDS 2 AND CHLORIDE-DEPENDENT GLYCINE TRANSPORTER 2, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR R.P.CANTWELL CHATER,J.PEISER-OLIVER,T.K.PATI,A.S.QUINN,I.LOTSARIS, AUTHOR 2 Z.J.FRANGOS,K.E.ANDERSON,A.E.TISCHER,B.J.WILLIAMS-NOONAN,K.R.AUBREY, AUTHOR 3 M.L.O MARA,M.MICHAELIDES,S.A.MOHAMMADI,C.L.CIOFFI,R.J.VANDENBERG, AUTHOR 4 A.SHAHSAVAR REVDAT 1 25-FEB-26 9R1H 0 JRNL AUTH R.P.CANTWELL CHATER,J.PEISER-OLIVER,T.K.PATI,A.S.QUINN, JRNL AUTH 2 I.LOTSARIS,Z.J.FRANGOS,K.E.ANDERSON,A.E.TISCHER, JRNL AUTH 3 B.J.WILLIAMS-NOONAN,K.R.AUBREY,M.L.O'MARA,M.MICHAELIDES, JRNL AUTH 4 S.A.MOHAMMADI,C.L.CIOFFI,R.J.VANDENBERG,A.SHAHSAVAR JRNL TITL A REVERSIBLE ALLOSTERIC INHIBITOR OF GLYT2 FOR NEUROPATHIC JRNL TITL 2 PAIN WITHOUT ON-TARGET SIDE EFFECTS. JRNL REF NAT COMMUN 2026 JRNL REFN ESSN 2041-1723 JRNL PMID 41698908 JRNL DOI 10.1038/S41467-026-69616-5 REMARK 2 REMARK 2 RESOLUTION. 3.02 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : PHENIX, CRYOSPARC, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.020 REMARK 3 NUMBER OF PARTICLES : 162255 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9R1H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-MAY-25. REMARK 100 THE DEPOSITION ID IS D_1292147355. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HUMAN GLYCINE TRANSPORTER GLYT2 REMARK 245 BOUND TO SUBSTRATE GLYCINE REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 14962 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : FEI FALCON IV (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 600.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1800.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 165000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 185 REMARK 465 ASP A 186 REMARK 465 GLU A 187 REMARK 465 ASN A 188 REMARK 465 LYS A 189 REMARK 465 ALA A 190 REMARK 465 ARG A 191 REMARK 465 GLY A 192 REMARK 465 ASN A 193 REMARK 465 TRP A 194 REMARK 465 LEU A 327 REMARK 465 LEU A 328 REMARK 465 ASP A 329 REMARK 465 SER A 330 REMARK 465 CYS A 331 REMARK 465 VAL A 332 REMARK 465 ILE A 333 REMARK 465 SER A 334 REMARK 465 ASP A 335 REMARK 465 HIS A 336 REMARK 465 PRO A 337 REMARK 465 LYS A 338 REMARK 465 ILE A 339 REMARK 465 GLN A 340 REMARK 465 ILE A 341 REMARK 465 LYS A 342 REMARK 465 ASN A 343 REMARK 465 SER A 344 REMARK 465 THR A 345 REMARK 465 PHE A 346 REMARK 465 CYS A 347 REMARK 465 MET A 348 REMARK 465 THR A 349 REMARK 465 ALA A 350 REMARK 465 TYR A 351 REMARK 465 PRO A 352 REMARK 465 ASN A 353 REMARK 465 VAL A 354 REMARK 465 THR A 355 REMARK 465 MET A 356 REMARK 465 VAL A 357 REMARK 465 ASN A 358 REMARK 465 PHE A 359 REMARK 465 THR A 360 REMARK 465 SER A 361 REMARK 465 GLN A 362 REMARK 465 ALA A 363 REMARK 465 ASN A 364 REMARK 465 LYS A 365 REMARK 465 ILE A 415 REMARK 465 LYS A 416 REMARK 465 THR A 417 REMARK 465 SER A 418 REMARK 465 GLY A 419 REMARK 465 LEU A 786 REMARK 465 PRO A 787 REMARK 465 VAL A 788 REMARK 465 LYS A 789 REMARK 465 ASP A 790 REMARK 465 LEU A 791 REMARK 465 GLU A 792 REMARK 465 LEU A 793 REMARK 465 GLY A 794 REMARK 465 THR A 795 REMARK 465 GLN A 796 REMARK 465 CYS A 797 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 537 37.13 -141.91 REMARK 500 SER A 638 -84.56 -112.80 REMARK 500 PHE A 683 -57.22 -121.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 769 0.22 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 801 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLY A 206 O REMARK 620 2 TYR A 207 O 77.8 REMARK 620 3 VAL A 209 O 81.6 86.1 REMARK 620 4 LEU A 574 O 137.9 143.9 93.3 REMARK 620 5 ASP A 577 OD1 99.6 124.0 149.6 65.4 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 9HUG RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN BUT IN SUBSTRATE-FREE STATE REMARK 900 RELATED ID: 9HUF RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN BUT BOUND TO ALLOSTERIC INHIBITOR RPI- REMARK 900 GLYT2-82 REMARK 900 RELATED ID: 9HUE RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN BUT BOUND TO ALLOSTERIC INHIBITOR ORG25543 REMARK 900 RELATED ID: EMD-53509 RELATED DB: EMDB REMARK 900 INWARD-OCCLUDED STRUCTURE OF HUMAN GLYCINE TRANSPORTER 2 BOUND TO REMARK 900 SUBSTRATE GLYCINE DBREF 9R1H A 186 797 UNP Q9Y345 SC6A5_HUMAN 186 797 SEQADV 9R1H MET A 185 UNP Q9Y345 INITIATING METHIONINE SEQRES 1 A 613 MET ASP GLU ASN LYS ALA ARG GLY ASN TRP SER SER LYS SEQRES 2 A 613 LEU ASP PHE ILE LEU SER MET VAL GLY TYR ALA VAL GLY SEQRES 3 A 613 LEU GLY ASN VAL TRP ARG PHE PRO TYR LEU ALA PHE GLN SEQRES 4 A 613 ASN GLY GLY GLY ALA PHE LEU ILE PRO TYR LEU MET MET SEQRES 5 A 613 LEU ALA LEU ALA GLY LEU PRO ILE PHE PHE LEU GLU VAL SEQRES 6 A 613 SER LEU GLY GLN PHE ALA SER GLN GLY PRO VAL SER VAL SEQRES 7 A 613 TRP LYS ALA ILE PRO ALA LEU GLN GLY CYS GLY ILE ALA SEQRES 8 A 613 MET LEU ILE ILE SER VAL LEU ILE ALA ILE TYR TYR ASN SEQRES 9 A 613 VAL ILE ILE CYS TYR THR LEU PHE TYR LEU PHE ALA SER SEQRES 10 A 613 PHE VAL SER VAL LEU PRO TRP GLY SER CYS ASN ASN PRO SEQRES 11 A 613 TRP ASN THR PRO GLU CYS LYS ASP LYS THR LYS LEU LEU SEQRES 12 A 613 LEU ASP SER CYS VAL ILE SER ASP HIS PRO LYS ILE GLN SEQRES 13 A 613 ILE LYS ASN SER THR PHE CYS MET THR ALA TYR PRO ASN SEQRES 14 A 613 VAL THR MET VAL ASN PHE THR SER GLN ALA ASN LYS THR SEQRES 15 A 613 PHE VAL SER GLY SER GLU GLU TYR PHE LYS TYR PHE VAL SEQRES 16 A 613 LEU LYS ILE SER ALA GLY ILE GLU TYR PRO GLY GLU ILE SEQRES 17 A 613 ARG TRP PRO LEU ALA LEU CYS LEU PHE LEU ALA TRP VAL SEQRES 18 A 613 ILE VAL TYR ALA SER LEU ALA LYS GLY ILE LYS THR SER SEQRES 19 A 613 GLY LYS VAL VAL TYR PHE THR ALA THR PHE PRO TYR VAL SEQRES 20 A 613 VAL LEU VAL ILE LEU LEU ILE ARG GLY VAL THR LEU PRO SEQRES 21 A 613 GLY ALA GLY ALA GLY ILE TRP TYR PHE ILE THR PRO LYS SEQRES 22 A 613 TRP GLU LYS LEU THR ASP ALA THR VAL TRP LYS ASP ALA SEQRES 23 A 613 ALA THR GLN ILE PHE PHE SER LEU SER ALA ALA TRP GLY SEQRES 24 A 613 GLY LEU ILE THR LEU SER SER TYR ASN LYS PHE HIS ASN SEQRES 25 A 613 ASN CYS TYR ARG ASP THR LEU ILE VAL THR CYS THR ASN SEQRES 26 A 613 SER ALA THR SER ILE PHE ALA GLY PHE VAL ILE PHE SER SEQRES 27 A 613 VAL ILE GLY PHE MET ALA ASN GLU ARG LYS VAL ASN ILE SEQRES 28 A 613 GLU ASN VAL ALA ASP GLN GLY PRO GLY ILE ALA PHE VAL SEQRES 29 A 613 VAL TYR PRO GLU ALA LEU THR ARG LEU PRO LEU SER PRO SEQRES 30 A 613 PHE TRP ALA ILE ILE PHE PHE LEU MET LEU LEU THR LEU SEQRES 31 A 613 GLY LEU ASP THR MET PHE ALA THR ILE GLU THR ILE VAL SEQRES 32 A 613 THR SER ILE SER ASP GLU PHE PRO LYS TYR LEU ARG THR SEQRES 33 A 613 HIS LYS PRO VAL PHE THR LEU GLY CYS CYS ILE CYS PHE SEQRES 34 A 613 PHE ILE MET GLY PHE PRO MET ILE THR GLN GLY GLY ILE SEQRES 35 A 613 TYR MET PHE GLN LEU VAL ASP THR TYR ALA ALA SER TYR SEQRES 36 A 613 ALA LEU VAL ILE ILE ALA ILE PHE GLU LEU VAL GLY ILE SEQRES 37 A 613 SER TYR VAL TYR GLY LEU GLN ARG PHE CYS GLU ASP ILE SEQRES 38 A 613 GLU MET MET ILE GLY PHE GLN PRO ASN ILE PHE TRP LYS SEQRES 39 A 613 VAL CYS TRP ALA PHE VAL THR PRO THR ILE LEU THR PHE SEQRES 40 A 613 ILE LEU CYS PHE SER PHE TYR GLN TRP GLU PRO MET THR SEQRES 41 A 613 TYR GLY SER TYR ARG TYR PRO ASN TRP SER MET VAL LEU SEQRES 42 A 613 GLY TRP LEU MET LEU ALA CYS SER VAL ILE TRP ILE PRO SEQRES 43 A 613 ILE MET PHE VAL ILE LYS MET HIS LEU ALA PRO GLY ARG SEQRES 44 A 613 PHE ILE GLU ARG LEU LYS LEU VAL CYS SER PRO GLN PRO SEQRES 45 A 613 ASP TRP GLY PRO PHE LEU ALA GLN HIS ARG GLY GLU ARG SEQRES 46 A 613 TYR LYS ASN MET ILE ASP PRO LEU GLY THR SER SER LEU SEQRES 47 A 613 GLY LEU LYS LEU PRO VAL LYS ASP LEU GLU LEU GLY THR SEQRES 48 A 613 GLN CYS HET NA A 801 1 HET CL A 802 1 HET GLY A 803 5 HETNAM NA SODIUM ION HETNAM CL CHLORIDE ION HETNAM GLY GLYCINE FORMUL 2 NA NA 1+ FORMUL 3 CL CL 1- FORMUL 4 GLY C2 H5 N O2 FORMUL 5 HOH *2(H2 O) HELIX 1 AA1 SER A 195 VAL A 209 1 15 HELIX 2 AA2 GLY A 210 TRP A 215 1 6 HELIX 3 AA3 TRP A 215 GLY A 225 1 11 HELIX 4 AA4 PHE A 229 ALA A 240 1 12 HELIX 5 AA5 ALA A 240 SER A 256 1 17 HELIX 6 AA6 SER A 261 ALA A 268 5 8 HELIX 7 AA7 LEU A 269 PHE A 302 1 34 HELIX 8 AA8 LEU A 306 SER A 310 5 5 HELIX 9 AA9 GLY A 370 PHE A 378 1 9 HELIX 10 AB1 ARG A 393 LYS A 413 1 21 HELIX 11 AB2 VAL A 421 ALA A 426 1 6 HELIX 12 AB3 THR A 427 THR A 442 1 16 HELIX 13 AB4 GLY A 445 THR A 455 1 11 HELIX 14 AB5 GLU A 459 THR A 462 5 4 HELIX 15 AB6 ASP A 463 SER A 479 1 17 HELIX 16 AB7 GLY A 483 TYR A 491 1 9 HELIX 17 AB8 ASN A 497 LYS A 532 1 36 HELIX 18 AB9 ASN A 534 VAL A 538 5 5 HELIX 19 AC1 GLY A 544 THR A 555 1 12 HELIX 20 AC2 LEU A 559 ASP A 592 1 34 HELIX 21 AC3 PHE A 594 ARG A 599 1 6 HELIX 22 AC4 HIS A 601 GLY A 617 1 17 HELIX 23 AC5 PHE A 618 ILE A 621 5 4 HELIX 24 AC6 GLY A 624 ALA A 637 1 14 HELIX 25 AC7 SER A 638 VAL A 655 1 18 HELIX 26 AC8 GLY A 657 GLY A 670 1 14 HELIX 27 AC9 ASN A 674 PHE A 683 1 10 HELIX 28 AD1 PHE A 683 GLN A 699 1 17 HELIX 29 AD2 PRO A 711 ILE A 727 1 17 HELIX 30 AD3 ILE A 727 ALA A 740 1 14 HELIX 31 AD4 ARG A 743 VAL A 751 1 9 HELIX 32 AD5 LEU A 762 GLY A 767 5 6 SHEET 1 AA1 2 CYS A 320 LYS A 321 0 SHEET 2 AA1 2 VAL A 368 SER A 369 1 O VAL A 368 N LYS A 321 SHEET 1 AA2 2 THR A 704 TYR A 705 0 SHEET 2 AA2 2 TYR A 708 ARG A 709 -1 O TYR A 708 N TYR A 705 LINK O GLY A 206 NA NA A 801 1555 1555 2.32 LINK O TYR A 207 NA NA A 801 1555 1555 2.80 LINK O VAL A 209 NA NA A 801 1555 1555 2.34 LINK O LEU A 574 NA NA A 801 1555 1555 3.14 LINK OD1 ASP A 577 NA NA A 801 1555 1555 2.31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 89 4354 CONECT 93 4354 CONECT 110 4354 CONECT 2634 4354 CONECT 2657 4354 CONECT 4354 89 93 110 2634 CONECT 4354 2657 MASTER 230 0 3 32 4 0 0 6 4361 1 7 48 END